Explore

Trendline Trendline
Paul Spreen Appointed as Chief Commercial Officer to Drive Growth at Premier Research

Paul Spreen Appointed as Chief Commercial Officer to Drive Growth at Premier Research

Paul Spreen Appointed as Chief Commercial Officer to Drive Growth at Premier Research
Trendline Trendline
Gilead Acquires Tubulis for $5 Billion to Enhance Oncology Pipeline

Gilead Acquires Tubulis for $5 Billion to Enhance Oncology Pipeline

Gilead Acquires Tubulis for $5 Billion to Enhance Oncology Pipeline
Trendline Trendline
Gilead Sciences Acquires Tubulis in $5 Billion Deal to Expand Oncology Portfolio

Gilead Sciences Acquires Tubulis in $5 Billion Deal to Expand Oncology Portfolio

Gilead Sciences Acquires Tubulis in $5 Billion Deal to Expand Oncology Portfolio
Trendline Trendline
CenExel Appoints Dr. Sy Pretorius as New CEO to Drive Strategic Growth

CenExel Appoints Dr. Sy Pretorius as New CEO to Drive Strategic Growth

CenExel Appoints Dr. Sy Pretorius as New CEO to Drive Strategic Growth
Trendline Trendline
TriNetX Acquires Zetta Genomics Assets to Enhance Federated Health Data Network

TriNetX Acquires Zetta Genomics Assets to Enhance Federated Health Data Network

TriNetX Acquires Zetta Genomics Assets to Enhance Federated Health Data Network
Trendline Trendline
Gilead to Acquire Tubulis GmbH in $5 Billion Deal to Enhance Cancer Drug Pipeline

Gilead to Acquire Tubulis GmbH in $5 Billion Deal to Enhance Cancer Drug Pipeline

Gilead to Acquire Tubulis GmbH in $5 Billion Deal to Enhance Cancer Drug Pipeline
Trendline Trendline
TriNetX Acquires Zetta Genomics to Enhance Global Genomics Data Federation

TriNetX Acquires Zetta Genomics to Enhance Global Genomics Data Federation

TriNetX Acquires Zetta Genomics to Enhance Global Genomics Data Federation
Trendline Trendline
CGBIO Secures KRW 5.3 Billion in Contracts at KIMES 2026, Expanding Global Medical Device Reach

CGBIO Secures KRW 5.3 Billion in Contracts at KIMES 2026, Expanding Global Medical Device Reach

CGBIO Secures KRW 5.3 Billion in Contracts at KIMES 2026, Expanding Global Medical Device Reach
Trendline Trendline
Texas Biopharma Industry Sees Surge in Job Openings Amid Economic Growth

Texas Biopharma Industry Sees Surge in Job Openings Amid Economic Growth

Texas Biopharma Industry Sees Surge in Job Openings Amid Economic Growth
Trendline Trendline
Gilead Sciences Expands Oncology Portfolio with $5 Billion Tubulis Acquisition

Gilead Sciences Expands Oncology Portfolio with $5 Billion Tubulis Acquisition

Gilead Sciences Expands Oncology Portfolio with $5 Billion Tubulis Acquisition
Trendline Trendline
ABION's Preclinical Data Shows ABN202 Outperforms TROP2-Targeting ADCs in Cancer Treatment

ABION's Preclinical Data Shows ABN202 Outperforms TROP2-Targeting ADCs in Cancer Treatment

ABION's Preclinical Data Shows ABN202 Outperforms TROP2-Targeting ADCs in Cancer Treatment
Trendline Trendline
Gilead Acquires Tubulis GmbH in $5 Billion Deal to Enhance Cancer Drug Pipeline

Gilead Acquires Tubulis GmbH in $5 Billion Deal to Enhance Cancer Drug Pipeline

Gilead Acquires Tubulis GmbH in $5 Billion Deal to Enhance Cancer Drug Pipeline